Heartsciences provides business update and reports third quarter fiscal 2025 financial results

Southlake, tx, march 13, 2025 (globe newswire) -- heartsciences inc. (nasdaq: hscs; hscsw) ("heartsciences" or the "company"), an artificial intelligence (“ai”)-powered medical technology company focused on transforming ecgs/ekgs to save lives through earlier detection of heart disease, today reported financial results for the third quarter fiscal 2025 ended january 31, 2025 and provided a business update.
HSCS Ratings Summary
HSCS Quant Ranking